INDEX OF MATERIALS & TOOLS
Quick access to helpful in-office professional and patient resources
BENLYSTA Gateway Enrollment Form with PIEnglish language Spanish language
Considering BENLYSTA IV for PatientsEnglish language
Patient BrochureEnglish language
Getting Started on IV for PatientsEnglish language
Patient Communication Journal for IVEnglish language Spanish language Chinese language
Find the vial combination that helps minimize product waste
Calculate patients' infusion dates
Additional practical dosing information and tools can be found on the Dosing & Administration page
Brochures and forms for accessing BENLYSTA are available on the Access & Support page
Helpful tools to identify patients appropriate for BENLYSTA are found on the Identifying Patients page
Videos and brochures review the pivotal trials on the Efficacy page
e-Lecture video series about SLE and Benlysta
Five informative videos have been developed that detail SLE and its treatment with BENLYSTA.
They are also found throughout this site.
Watch Clinical Trials:
Efficacy and Safety of BENLYSTA
Gain an understanding of the BLISS IV clinical trials supporting the efficacy and safety of BENLYSTA.
Watch BENLYSTA for
the Treatment of SLE
Discover information on the mechanism of action of BENLYSTA and the clinical trials supporting the efficacy and safety of BENLYSTA.
Active SLE Disease
Get an overview of several assessment tools for measuring disease activity, including SELENA-SLEDAI, BILAG, and PGA.
Meet the Experts
Jennifer Sloan, MD
Dr. Sloane is a Medical Director for Immuno-inflammation in US Medical Affairs at GSK. She is board certified in internal medicine and rheumatology.
Prior to joining GSK in 2015, Dr. Sloane held faculty positions at Temple University and Thomas Jefferson University. In addition to seeing patients, Dr. Sloane was a rheumatology fellowship director. She was also involved in several projects focusing on rheumatology education.
Dr. Sloane received her medical degree from Albert Einstein College of Medicine of Yeshiva University and completed her residency in internal medicine and fellowship in rheumatology at New York University Medical Center.
William Eastman, MD
Dr. Eastman is a Medical Director and US Medical Affairs Lead for the Immuno-inflammation Therapeutic Area at GSK. In this role, Dr. Eastman oversees US medical support for systemic lupus erythematosus (SLE) assets at GSK. He previously served as Medical Director, US Medical Affairs Lead for the dermatology therapeutic area at GSK.
Dr. Eastman received his medical degree from East Carolina University School of Medicine, where he was a Brody Scholar. He trained in internal medicine at Duke University Medical Center.
Dr. Eastman has 22 years of pharmaceutical industry experience, with leadership roles in medical affairs, pharmacovigilance, clinical project management, medical writing, and data management.
Tania González-Rivera, MD
Tania González-Rivera joined GSK in 2016 as an Immuno-inflammation Medical Director.
Dr. Gonzalez-Rivera is a rheumatologist who specializes in lupus and was an investigator for several lupus clinical trials. Prior to joining GSK, Tania held faculty positions at the University of Pennsylvania and the University of Michigan. She continues to be involved in patient care at the Corporal Michael J. Crescenz Veteran’s Affairs Medical Center in Philadelphia, PA twice a month. Tania is certified by the American Board of Internal Medicine and Rheumatology.
She received her medical degree and completed her residency in Internal Medicine at the University of Puerto Rico and a fellowship in Rheumatology at the University of Michigan Health System.
831197R0 February 2018